Convergent functional genomics: Application to bipolar disorder

Annals of Medicine

Volumn 33, Issue 4, 2001, Pages 263-271

  Niculescu III, A B ^a   Kelsoe, J R ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Bipolar disorder; Functional genomics; Gene expression profiling; Mania; Manic depressive illness; Microarrays; Psychosis

Indexed keywords

MESSENGER RNA;

CADAVER; GENE EXPRESSION; GENOME; MANIA; MANIC DEPRESSIVE PSYCHOSIS; MENTAL DISEASE; MOLECULAR CLONING; MOOD; PHENOTYPE; PRIORITY JOURNAL; PSYCHOSIS; REVIEW;

EID: 0034981514     PISSN: 07853890     EISSN: None     Source Type: Journal    
DOI: 10.3109/07853890108998755     Document Type: Review

References (33)

1. The genetics of mood disorders
2. True and false positive peaks in genomewide scans: Applications of length-biased sampling to linkage mapping
3. Identifying a series of candidate genes for mania and psychosis: A convergent functional genomics approach
4. Molecular characterization of schizophrenia viewed by microarray analysis of gene expression in prefrontal cortex
5. The "chip" as a specific genetic tool
6. Application of DNA microarrays to study human alcoholism
7. An animal model for mania: Preliminary results
8. Lithium prevents ouabain-induced behavioral changes. Toward an animal model for manic depression
9. Open field is more sensitive than automated activity monitor in documenting ouabain-induced hyperlocomotion in the development of an animal model for bipolar illness
10. Alpha 2 isoform of the Na,K-adenosine triphosphatase is reduced in temporal cortex of bipolar individuals
11. Sleep deprivation in the rat: An animal model of mania
12. A pharmacologically pertinent animal model of mania
13. The dopamine hypothesis of schizophrenia and mood disorders: Contradictions and speculations
14. Dextroamphetamine-induced arousal in human subjects as a model for mania
15. Amphetamine psychosis: Clinical variations of the syndrome
16. Dopaminergic mechanisms in depression and mania
17. Neuroscience of addiction
18. Animal models of stimulant-induced psychosis
19. Enduring changes in brain and behavior produced by chronic amphetamine administration: A review and evaluation of animal models of amphetamine psychosis
20. An escalating dose "binge" model of amphetamine psychosis: Behavioral and neurochemical characteristics
21. Amphetamine psychosis and psychotic symptoms
22. Chronic lithium attenuates dopamine D1-receptor mediated increases in acetylcholine release in rat frontal cortex
23. Differential regional zif268 messenger RNA expression in an escalating dose/binge model of amphetamine-induced psychosis
24. Hippocampal synaptic pathology in schizophrenia, bipolar disorder and major depression: A study of complexin mRNAs
25. Temporally defined induction of c-fos in the rat pineal
26. Reduced neuropeptide Y mRNA expression in the prefrontal cortex of subjects with bipolar disorder
27. VASE-containing N-CAM isoforms are increased in the hippocampus in bipolar disorder but not schizophrenia
28. A genome survey indicates a possible susceptibility locus for bipolar disorder on chromosome 22
29. Initial genomic scan of the NIMH genetics initiative bipolar pedigrees: Chromosomes 3, 5, 15, 16, 17, and 22
30. A high-density genome scan detects evidence for a bipolar-disorder susceptibility locus on 13q32 and other potential loci on 1q32 and 18p11.2
31. Brainology
32. Endophenotypes of dysthymia: Evolutionary, clinical and pharmacogenomic considerations